Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: Anxiety in Those Patients With Anorexia Nervosa, Eating Disorder Not Otherwise Specified, BMI (<=18)

In brief

The purpose of this study is to determine the effectiveness of hydroxyzine in the treatment of meal-related anxiety in adolescents and young adults 8 to 25 years of age diagnosed with an eating disorder who are underweight. The investigators want to find out if hydroxyzine given before meals will improve meal-related anxiety compared to no hydroxyzine.

Key facts

Study ID: NCT01372670
Run by: HealthPartners Institute
People needed: 0
Starts: 2012-01-01
Expected to finish: 2013-04-01
Last updated by the study team: 2016-11-15

Who can join

Age: 8 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Admitted to the Intensive Structured Living Unit (ISL) at Melrose Institute for treatment of an eating disorder that meets DSM-IV criteria for Anorexia Nervosa (excluding the amenorrhea criterion), or Eating Disorder Not Otherwise Specified, specifically with BMI (≤ 18)
Age 8-25 years old at admission to ISL.
Weight ≥ 15 kg at admission to ISL.
Stable psychotropic and/or sedative medications for at least (≥) 6 weeks

You may not qualify if…

Age < 8 years
Age ≥ 25 years
Weight < 15 kg at admission to ISL
Prolonged QT interval on ECG at admission to ISL
Current substance or alcohol abuse or dependence
Malabsorption syndrome or inability to take oral medications
History of hydroxyzine intolerance or hypersensitivity
History of Type 1 Diabetes Mellitus
History of angle closure glaucoma
Currently on another clinical trial
Pregnancy

Where it is running

Melrose Institute — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.